Modified Cortex Mori Capsules improving the successful rate of functional filtering blebs after reclinical glaucoma filtering surgery

Table 1 The variance text between surgery and placebo and surgery and Modified Cortex Mori Capsules

	Placebo	MCMC	P value
Gender	1.20 ± 0.23	1.19 ± 0.281	> 0.05
Age	40.30 ± 8.82	39.79 ± 6.15	> 0.05
IOP	38.20 ± 2.47	37.88 ± 3.16	> 0.05
C/D	0.70 ± 0.32	0.70 ± 0.17	> 0.05
Surgery times	1.35 ± 0.56	1.33 ± 0.53	> 0.05

¹For male, ²For female. MCMC: Modified cortex mori capsules.

Table 2 The rate of functional filtering bleb

	Placebo	MCMC	P value
Functional filtering bleb	16	21
Dysfunctional filtering bleb	9	4
Rate, %	64	84	< 0.05

MCMC: Modified cortex mori capsules.

Table 3 The complications after trabeculectomy surgery at 6 mo

	Placebo	MCMC	P value
Corneal epithelium damage	7	5	> 0.05
Conjunctiva wound leakage	0	0	> 0.05
Shallow anterior chamber	2	1	> 0.05
Uveitis	0	0	> 0.05
Low IOP	0	0	> 0.05
Choroid detachment	0	0	> 0.05
Progressive lens opacity	2	2	> 0.05
Endophthalmitis	0	0	> 0.05
Filtering bleb rupture	0	0	> 0.05

IOP: Intraocular pressure; MCMC: Modified cortex mori capsules.